These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15385728)

  • 1. Epoetin alfa for treatment of anemia in HIV-infected patients: past, present, and future.
    Henry DH; Volberding PA; Leitz G
    J Acquir Immune Defic Syndr; 2004 Oct; 37(2):1221-7. PubMed ID: 15385728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epoetin alfa therapy for anaemia in HIV-infected patients: impact on quality of life.
    Abrams DI; Steinhart C; Frascino R
    Int J STD AIDS; 2000 Oct; 11(10):659-65. PubMed ID: 11057937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Once-weekly epoetin alfa dosing is as effective as three times-weekly dosing in increasing hemoglobin levels and is associated with improved quality of life in anemic HIV-infected patients.
    Grossman HA; Goon B; Bowers P; Leitz G;
    J Acquir Immune Defic Syndr; 2003 Dec; 34(4):368-78. PubMed ID: 14615654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epoetin alfa. Clinical evolution of a pleiotropic cytokine.
    Henry DH; Bowers P; Romano MT; Provenzano R
    Arch Intern Med; 2004 Feb; 164(3):262-76. PubMed ID: 14769622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of epoetin alfa administered every 2 weeks to maintain hemoglobin and quality of life in anemic HIV-infected patients.
    Levine AM; Salvato P; Leitz GJ;
    AIDS Res Hum Retroviruses; 2008 Feb; 24(2):131-9. PubMed ID: 18284320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once-weekly epoetin alfa improves quality of life and increases hemoglobin in anemic HIV+ patients.
    Saag MS; Bowers P; Leitz GJ; Levine AM;
    AIDS Res Hum Retroviruses; 2004 Oct; 20(10):1037-45. PubMed ID: 15587490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting the hematopoietic response to recombinant human erythropoietin (Epoetin alfa) in the treatment of the anemia of cancer.
    Adamson JW; Ludwig H
    Oncology; 1999; 56(1):46-53. PubMed ID: 9885377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Epoetin alfa on hemostasis in chronic renal failure.
    Tang WW; Stead RA; Goodkin DA
    Am J Nephrol; 1998; 18(4):263-73. PubMed ID: 9653828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin, the biology of erythropoiesis and epoetin alfa. An overview.
    Bieber E
    J Reprod Med; 2001 May; 46(5 Suppl):521-30. PubMed ID: 11396386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of Epoetin alfa on quality of life in anemic cancer patients.
    Cella D; Bron D
    Cancer Pract; 1999; 7(4):177-82. PubMed ID: 10687582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weekly epoetin alfa during adjuvant chemotherapy for breast cancer: effect on hemoglobin levels and quality of life.
    Hudis CA; Vogel CL; Gralow JR; Williams D;
    Clin Breast Cancer; 2005 Jun; 6(2):132-42. PubMed ID: 16001991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with epoetin alfa and acquired immunodeficiency syndrome anemia.
    Henry DH
    Semin Oncol; 1998 Jun; 25(3 Suppl 7):64-8. PubMed ID: 9671334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does epoetin alfa improve health-related quality of life in chronically ill patients with anemia? Summary of trials of cancer, HIV/AIDS, and chronic kidney disease.
    Kimel M; Leidy NK; Mannix S; Dixon J
    Value Health; 2008; 11(1):57-75. PubMed ID: 18237361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a place for epoetin alfa in managing anemia during critical illness?
    Givens M; Lapointe M
    Clin Ther; 2004 Jun; 26(6):819-29. PubMed ID: 15262453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epoetin alfa treatment results in clinically significant improvements in quality of life in anemic cancer patients when referenced to the general population.
    Cella D; Zagari MJ; Vandoros C; Gagnon DD; Hurtz HJ; Nortier JW
    J Clin Oncol; 2003 Jan; 21(2):366-73. PubMed ID: 12525531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epoetin alfa therapy increases hemoglobin levels and improves quality of life in patients with cancer-related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemotherapy.
    Quirt I; Robeson C; Lau CY; Kovacs M; Burdette-Radoux S; Dolan S; Tang SC; McKenzie M; Couture F;
    J Clin Oncol; 2001 Nov; 19(21):4126-34. PubMed ID: 11689580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Italian gynecological consensus statement on the use of epoetin alfa in the management of anemia.
    Pecorelli S;
    Semin Oncol; 2002 Jun; 29(3 Suppl 8):13-5. PubMed ID: 12082648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of epoetin alfa in chemotherapy patients: a consistent profile of efficacy and safety.
    Itri LM
    Semin Oncol; 2002 Jun; 29(3 Suppl 8):81-7. PubMed ID: 12082659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted molecular mechanisms of epoetin alfa.
    Langer CJ; Hirsch FR; Cortés-Funes H; Sawyer ST; Thatcher N
    Lung Cancer; 2003 Aug; 41 Suppl 1():S133-45. PubMed ID: 12867072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits associated with an early hemoglobin response to epoetin alfa therapy in the treatment of chemotherapy-related anemia.
    Campos SM; Duh MS; Lefebvre P; Rosberg J
    J Natl Compr Canc Netw; 2005 Nov; 3(6):807-16. PubMed ID: 16316616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.